发明名称 CD40 BINDING MOLECULES AND CTL PEPTIDES FOR TREATING TUMORS
摘要 <p>Disclosed is a method and composition for treating tumors or infectious diseases, wherein the composition includes CD40 binding molecules together with CTL-activating peptides, e.g., tumor antigens. Such composition is useful for enhancing the anti-tumor affect of a peptide tumor vaccine, or for otherwise activating CTLs so that the activated CTLs can act against tumurous or infected cells. The CD40 binding molecules can include antibody molecules, as well as homologues, analogues and modified or derived forms thereof, including immunoglobulin fragments like Fab. (Fab')2 and Fv, as well as other molecules including peptides, oligonucleotides, peptidomimetics and organic compounds which bind to CD-40 and activate the CTL response.</p>
申请公布号 EP1082141(A4) 申请公布日期 2002.08.07
申请号 EP19990937841 申请日期 1999.05.21
申请人 LEIDEN UNIVERSITY MEDICAL CENTER;TANOX, INC. 发明人 MELIEF, CORNELIS J. M.;OFFRINGA, RIENK;TOES, RENE;SCHOENBERGER, STEPHEN P.;DE BOER, MARK
分类号 C12N15/09;A61K35/12;A61K38/00;A61K39/395;A61K45/00;A61K48/00;A61P35/00;C07K14/025;C07K14/075;C07K14/47;C07K16/18;C07K16/28;C12N1/15;C12N1/19;C12N1/21;C12N5/10;(IPC1-7):A61K48/00;A61K35/00;C12N15/63;C12N15/85;C07K14/705;C12N15/86 主分类号 C12N15/09
代理机构 代理人
主权项
地址